A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments

Clinical trial NCT05152472 · RECRUITING

Trial details

NCT number: NCT05152472
Sponsor: Centre Leon Berard
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Gastrointestinal Stromal Tumor (GIST)Locally Advanced Gastrointestinal Stromal Tumor (GIST)Metastatic Gastrointestinal Stromal Tumor

Start date: 2022-01-14
Primary completion: 2027-10-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.